2017 FDA drug approvals

被引：1
|
作者：
Mullard A.
机构：
来源：
Nature Reviews Drug Discovery | 2018年 / 17卷 / 2期
关键词：
D O I：
10.1038/nrd.2018.4
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：81 / 85
页数：4
相关论文
共 50 条
  • [41] Fda inspection shutdown delays drug approvals
    Wechsler, Jill
    Pharmaceutical Technology, 2021, 45 (02) : 14 - 15
  • [42] FDA Inspection Shutdown Delays Drug Approvals
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2021, 34 (02) : 10 - 11
  • [43] Survey finds delays in veterinary drug approvals at FDA
    不详
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2001, 218 (04) : 498 - 498
  • [44] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Zheng, Lang
    Wang, Wenjing
    Sun, Qiu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [45] FDA offers aid toward antiparasitic drug approvals
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 247 (10): : 1085 - 1085
  • [46] FDA offers aid toward antiparasitic drug approvals
    不详
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2015, 76 (12) : 1012 - 1012
  • [47] Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019
    Ruger, Jacqueline
    Ioannou, Silvia
    Castanotto, Daniela
    Stein, Cy A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (01) : 27 - 41
  • [48] FDA approvals
    不详
    AMERICAN FAMILY PHYSICIAN, 2003, 67 (12) : 2629 - 2629
  • [49] FDA approvals
    不详
    GERIATRICS, 2000, 55 (10) : 20 - 20
  • [50] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Lang Zheng
    Wenjing Wang
    Qiu Sun
    Signal Transduction and Targeted Therapy, 9
12345